Josephine Ornago, owner at OutspokenPR, creates a four-part series to raise awareness for the femtech market. This series starts with the critical issue of the destigmatisation of the female reproductive apparatus in its entirety.
Following the fund’s first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing.
In this article, Nick Allen, CEO at 3DPRINTUK and Neil Sewell, CEO, Solid Print3D will explore the decision-making for engaging with 3D printing, whether that is for in-house 3D printing or outsourcing to service providers.
Colin Spellacy, head of sales, Rösler UK analyses what mass finishing and shot blasting can be used for when processing medical devices and components.
Aengus Ó Curraidhín, senior medical design/development engineer at global engineering technologies company, Renishaw, shares his thoughts on what’s next in the MedTech sector.
Kevin Brownsill, head of technical: learning and development, Intertronics, shares advice on what to consider when specifying a structural adhesive for a high performance application.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications looks at the impact of delays in the introduction of value-based procurement.
Mike Ludlow, market development manager for E&L at Element Life Sciences shares how to ensure the safety of medical respiratory devices and the importance of the correct implementation of the ISO 18562 testing guidelines.
Olivia Simpson, CEO & co-founder of SymbioTex – a company that uses seaweed as a plastics replacement, shares why they chose seaweed and gives advice to start-up companies.
